
Flowonix
Medical device company developing solutions for patients with chronic disorders.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |






Related Content
Flowonix Medical Inc. is dedicated to advancing targeted drug delivery systems aimed at treating neurological disorders. The company focuses on designing, developing, and deploying patient-centric drug delivery platforms that provide physicians with optimal solutions for managing their patients' conditions. Operating in the medical technology market, Flowonix serves healthcare providers and patients who require specialized treatment for chronic pain and other neurological issues. The business model revolves around continuous research and development, ensuring that their products remain at the forefront of medical innovation. Flowonix generates revenue through the sale of its advanced drug delivery systems to healthcare institutions and practitioners. The company is headquartered in Mt. Olive, New Jersey, and remains committed to improving patient outcomes through cutting-edge technology.
Keywords: targeted drug delivery, neurological disorders, patient-centric, medical technology, chronic pain, healthcare providers, innovation, research and development, advanced systems, optimal solutions.